Tetraphase Pharmaceuticals buy melinda
Start price
26.02.18
/
50%
€47.60
Target price
27.02.18
€4.51
Performance (%)
4.97%
End price
27.02.18
€49.97
Summary
This prediction ended on 27.02.18 with a price of €49.97. With a performance of 4.97%, the BUY prediction by melinda for Tetraphase Pharmaceuticals closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Tetraphase Pharmaceuticals | - | - | - | - |
iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
Comments by melinda for this prediction
In the thread Tetraphase Pharmaceuticals diskutieren
Infektionen
Tetraphase Pharmaceuticals, Inc. engagiert in der Entwicklung und Produktion neuer Antibiotika für schwere bakterielle infections.It und die Prognose eines Produktkandidaten entwickelt, eravacycline
(Vom Mitglied beendet)
Stopped prediction by melinda for Tetraphase Pharmaceuticals
Tetraphase Pharmaceuticals
Start price
Target price
Perf. (%)
€0.22
03.03.20
03.03.20
€0.50
04.11.21
04.11.21
-
05.11.21
05.11.21
Tetraphase Pharmaceuticals
Start price
Target price
Perf. (%)
€14.08
25.05.19
25.05.19
€1.35
30.10.19
30.10.19
-98.45%
30.10.19
30.10.19
Tetraphase Pharmaceuticals
Start price
Target price
Perf. (%)
€50.15
28.09.18
28.09.18
€3.16
22.01.19
22.01.19
-55.40%
22.01.19
22.01.19
Tetraphase Pharmaceuticals
Start price
Target price
Perf. (%)
€148.11
25.04.17
25.04.17
€8.12
25.10.17
25.10.17
-24.85%
25.10.17
25.10.17
Tetraphase Pharmaceuticals
Start price
Target price
Perf. (%)
€70.35
03.02.17
03.02.17
€6.31
06.03.17
06.03.17
62.82%
06.03.17
06.03.17